Phenotypic Trends and Molecular Mechanisms of Helicobacter pylori Antibiotic Resistance in Bangladesh: A Scoping Review
Abstract
Objective: To comprehensively map the phenotypic prevalence, temporal trends, and molecular mechanisms of antimicrobial resistance in Helicobacter pylori isolates among patients in Bangladesh.
Method: Scoping review conducted in accordance with the JBI methodology and reported using the PRISMA-ScR checklist. A systematic search was conducted in PubMed, MEDLINE, Scopus, and BanglaJOL to identify peer-reviewed observational studies published between 1 January 2000 and 30 April 2025.
Results: Ten studies were reviewed. Metronidazole resistance remained persistently high (77.5%-96.4%), while clarithromycin rates surged from ~10% to > 39%. Levofloxacin resistance also reached critical levels (up to 66.1%). In contrast, amoxicillin (< 10%) and tetracycline (< 20%) retained efficacy. Genomic analysis linked resistance primarily to 23S rRNA (A2142G, A2143G) and gyrA mutations within hpAsia2 and hpEurope lineages.
Conclusion: The available evidence indicates a high and increasing burden of H. pylori antibiotic resistance in Bangladesh, particularly to clarithromycin, metronidazole, and levofloxacin. These findings highlight the need for updated, evidence-informed treatment strategies and expanded molecular surveillance to support effective eradication therapy.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.